INSULIN GLARGINE VERSUS METFORMIN FOR THE FIRST-LINE TREATMENT OF EARLY TYPE-2 DIABETES

• 收藏
• 分享

专利权人:

Wolfgang LANDGRAF

发明人:

Wolfgang LANDGRAF,Markolf HANEFELD

申请号：

US13692640

公开号：

US20130172246A1

申请日:

2012.12.03

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The invention relates to a method for treating type 2 diabetes patients, wherein insulin glargine is administered to the patient in an amount clinically tested to be safe and effective, wherein the type 2 diabetes is early type 2 diabetes, more particularly, wherein the insulin glargine is used as first-line drug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/